118 related articles for article (PubMed ID: 1850679)
21. Altered membrane microviscosity in essential hypertension: relationship with family history of hypertension and sodium-lithium countertransport activity.
Carr SJ; Sikand K; Moore D; Norman RI
J Hypertens; 1995 Jan; 13(1):139-46. PubMed ID: 7759844
[TBL] [Abstract][Full Text] [Related]
22. Alterations of membrane properties in erythrocytes of salt hypertensive Sabra rats.
Pernollet MG; David-Dufilho M; Zicha J; Kunes J; Devynck MA
Life Sci; 1994; 55(21):1625-32. PubMed ID: 7968237
[TBL] [Abstract][Full Text] [Related]
23. Changes of membrane fluidity in chemotactic peptide-stimulated polymorphonuclear leukocytes.
Valentino M; Governa M; Fiorini R; Curatola G
Biochem Biophys Res Commun; 1986 Dec; 141(3):1151-6. PubMed ID: 3814118
[TBL] [Abstract][Full Text] [Related]
24. Developmental changes in synaptic membrane fluidity: a comparison of 1,6-diphenyl-1,3,5-hexatriene (DPH) and 1-[4-(trimethylamino)phenyl]-6-phenyl-1,3,5-hexatriene (TMA-DPH).
Hitzemann RJ; Harris RA
Brain Res; 1984 May; 316(1):113-20. PubMed ID: 6733531
[TBL] [Abstract][Full Text] [Related]
25. Influence of dietary fatty acids on membrane fluidity and activation of rat platelets.
Heemskerk JW; Feijge MA; Kalafusz R; Hornstra G
Biochim Biophys Acta; 1989 Aug; 1004(2):252-60. PubMed ID: 2752022
[TBL] [Abstract][Full Text] [Related]
26. Effect of age on plasma membrane asymmetry and membrane fluidity in human leukocytes and platelets.
Noble JM; Thomas TH; Ford GA
J Gerontol A Biol Sci Med Sci; 1999 Dec; 54(12):M601-6. PubMed ID: 10647965
[TBL] [Abstract][Full Text] [Related]
27. Further analysis of cell membrane changes in genetic hypertension in rats by diphenylhexatriene fluorescence polarization.
Aragon-Birlouez I; Montenay-Garestier T; Devynck MA
Clin Sci (Lond); 1984 Jun; 66(6):717-23. PubMed ID: 6723208
[TBL] [Abstract][Full Text] [Related]
28. Fluorescence studies of the blood platelet membranes associated with fibrinogen.
Kowalska MA; Cierniewski CS
Biochim Biophys Acta; 1983 Apr; 729(2):275-80. PubMed ID: 6830792
[TBL] [Abstract][Full Text] [Related]
29. Oxidative response and membrane modification of diabetic platelets challenged with PAF.
Tiano L; Kantar A; Falcioni G; Littarru GP; Cherubini V; Fiorini R
Prostaglandins Other Lipid Mediat; 2000 Oct; 62(4):351-66. PubMed ID: 11060899
[TBL] [Abstract][Full Text] [Related]
30. Platelet and erythrocyte membrane changes in Alzheimer's disease.
Hajimohammadreza I; Brammer MJ; Eagger S; Burns A; Levy R
Biochim Biophys Acta; 1990 Jun; 1025(2):208-14. PubMed ID: 2142000
[TBL] [Abstract][Full Text] [Related]
31. In vivo shear flow and erythrocyte membrane fluidity in hypertensive patients.
Le Sang Quan KH; Levenson J; Del Pino M; Simon A; Devynck MA
Br J Clin Pharmacol; 1993 Nov; 36(5):437-43. PubMed ID: 12959291
[TBL] [Abstract][Full Text] [Related]
32. Cytoplasmic membrane fluidity measurements on intact living cells of Bacillus subtilis by fluorescence anisotropy of 1,6-diphenyl-1,3,5-hexatriene.
Svobodová J; Svoboda P
Folia Microbiol (Praha); 1988; 33(1):1-9. PubMed ID: 3129345
[TBL] [Abstract][Full Text] [Related]
33. Platelet membrane abnormality in Alzheimer's disease.
Zubenko GS; Cohen BM; Boller F; Malinakova I; Keefe N; Chojnacki B
Ann Neurol; 1987 Aug; 22(2):237-44. PubMed ID: 3662454
[TBL] [Abstract][Full Text] [Related]
34. Cell membrane microviscosity and Ca(2+)-Mg(2+)-ATPase activity do not contribute to hypertension in the spontaneously hypertensive rat model.
Norman RI; Achall N
Clin Sci (Lond); 1993 Nov; 85(5):585-91. PubMed ID: 8287647
[TBL] [Abstract][Full Text] [Related]
35. Plasma lipids and platelet membrane fluidity in essential hypertension.
Le Quan Sang KH; Mazeaud M; Astarie C; Duranthon V; Driss F; Devynck MA
Thromb Haemost; 1993 Jan; 69(1):70-6. PubMed ID: 8383361
[TBL] [Abstract][Full Text] [Related]
36. Type II diabetics with macrovascular complications: polymorphonuclear leukocyte (PMN) filtration, PMN membrane fluidity and cytosolic Ca2+ content after activation.
Caimi G; Lo Presti R; Montana M; Ferrara F; Ventimiglia G; Meli F; Catania A; Canino B
Horm Metab Res; 1998 Feb; 30(2):72-6. PubMed ID: 9543687
[TBL] [Abstract][Full Text] [Related]
37. Beta-estradiol effect on erythrocyte aggregation--a controlled in vitro study.
Gonçalves I; Saldanha C; Martins e Silva J
Clin Hemorheol Microcirc; 2001; 25(3-4):127-34. PubMed ID: 11847415
[TBL] [Abstract][Full Text] [Related]
38. A new analysis method for the membrane viscosity from steady-state fluorescence depolarization.
Araiso T; Koyama T
Biorheology; 1988; 25(1-2):253-9. PubMed ID: 3196822
[TBL] [Abstract][Full Text] [Related]
39. Blunted inhibition by insulin of agonist-stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients.
Touyz RM; Schiffrin EL
J Hypertens; 1994 Nov; 12(11):1255-63. PubMed ID: 7868873
[TBL] [Abstract][Full Text] [Related]
40. Parallel investigation of exocytosis kinetics and membrane fluidity changes in human platelets with the fluorescent probe, trimethylammonio-diphenylhexatriene.
Kubina M; Lanza F; Cazenave JP; Laustriat G; Kuhry JG
Biochim Biophys Acta; 1987 Jul; 901(1):138-46. PubMed ID: 3593721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
